Anixa begins Phase Ib trial of breast cancer vaccine

Anixa Biosciences has begun a Phase Ib clinical trial of its preventative breast cancer vaccine.

Being carried out at the Cleveland Clinic in the US, the trial will assess the safety and observe the immune response in subjects.